PharmaSGP Holding SE
Develops and markets leading natural OTC drugs for chronic conditions in the European market.
PSG | F
Overview
Corporate Details
- ISIN(s):
- DE000A2P4LJ5
- LEI:
- 3912005CZ12PVVCIPT91
- Country:
- Germany
- Address:
- Lochhamer Schlag 1, 82166 Gräfelfing
- Website:
- https://pharmasgp.com/english/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
PharmaSGP Holding SE is a pharmaceutical company specializing in the development and marketing of a broad portfolio of leading over-the-counter (OTC) drugs and other healthcare products. The company focuses on pharmacy-exclusive remedies based on natural pharmaceutical active ingredients with documented efficacy and minimal known side effects. Its core brands are market leaders in Germany and other European countries for chronic indications, including rheumatic and nerve pain (RubaXX®, Restaxil®), sleep disorders (Baldriparan®), and sexual weakness (DESEO®, NERADIN®). Since launching its first product in 2012, PharmaSGP has expanded its business model across Europe. The company's growth is driven by organic brand development and strategic acquisitions, such as its 2021 purchase of an OTC brand portfolio from GSK.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-22 15:15 |
Pre-Annual General Meeting Information
PharmaSGP convenes extraordinary general meeting to resolve on Squeeze-out
|
English | 7.3 KB | ||
| 2025-09-19 14:15 |
Report Publication Announcement
|
English | 3.9 KB | ||
| 2025-09-11 09:00 |
Earnings Release
PharmaSGP publishes preliminary half-year figures for 2025
|
English | 15.7 KB | ||
| 2025-08-14 12:00 |
Delisting Announcement
PharmaSGP Holding SE: FUTRUE GmbH, Tender of a total of 1,315 additional shares…
|
English | 6.8 KB | ||
| 2025-08-11 13:00 |
Delisting Announcement
PharmaSGP Holding SE: FUTRUE GmbH, Tender of a total of 39,678 additional share…
|
English | 6.8 KB | ||
| 2025-08-08 11:47 |
Director's Dealing
PharmaSGP Holding SE: FUTRUE GmbH, Tender of a total of 873 additional shares o…
|
English | 6.8 KB | ||
| 2025-08-07 13:11 |
Director's Dealing
PharmaSGP Holding SE: FUTRUE GmbH, Tender of a total of 1,505 additional shares…
|
English | 6.8 KB | ||
| 2025-08-06 16:16 |
Delisting Announcement
PharmaSGP Holding SE: Delisting of PharmaSGP shares from Frankfurt Stock Exchan…
|
English | 7.8 KB | ||
| 2025-08-05 10:48 |
Director's Dealing
PharmaSGP Holding SE: Michael Rudolf, Tender of 4,169 shares within the public …
|
English | 5.9 KB | ||
| 2025-08-04 13:58 |
Delisting Announcement
PharmaSGP Holding SE: Dr. Clemens Fischer, Tender of a total of 6,062 addition…
|
English | 6.6 KB | ||
| 2025-07-28 17:04 |
Delisting Announcement
PharmaSGP Holding SE publishes joint reasoned statement of the Management Board…
|
English | 9.2 KB | ||
| 2025-07-28 14:11 |
Delisting Announcement
PharmaSGP Holding SE: FUTRUE GmbH, Tender of an additional total of 4,491 share…
|
English | 6.9 KB | ||
| 2025-07-24 15:30 |
Director's Dealing
PharmaSGP Holding SE: FUTRUE GmbH, buy
|
English | 6.0 KB | ||
| 2025-07-24 14:11 |
Delisting Announcement
FUTRUE GmbH submits request to implement squeeze-out of minority shareholders o…
|
English | 8.2 KB | ||
| 2025-07-23 17:38 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 13.0 KB |
Automate Your Workflow. Get a real-time feed of all PharmaSGP Holding SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for PharmaSGP Holding SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2021-06-28 | MVH Beteiligungs- und Beratungs-GmbH | Close relation | Buy | None | 716,750.00 EUR |
| 2021-06-28 | FUTRUE GmbH | Close relation | Buy | None | 6,450,750.00 EUR |
